{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:19:14Z","timestamp":1776413954192,"version":"3.51.2"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T00:00:00Z","timestamp":1508976000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00105-017-4071-8","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T05:18:46Z","timestamp":1508995126000},"page":"64-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Secukinumab-induzierter subakut-kutaner Lupus erythematodes","Secukinumab-induced subacute-cutaneous lupus erythematosus"],"prefix":"10.1007","volume":"69","author":[{"given":"C.","family":"Wehrmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sondermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"K\u00f6rber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,10,26]]},"reference":[{"key":"4071_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1422.019","volume":"1108","author":"AT Borchers","year":"2007","unstructured":"Borchers AT, Keen CL, Gershwin ME (2007) Drug-induced lupus. Ann N Y Acad Sci 1108:166\u2013182","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"4071_CR2","first-page":"2503","volume":"12","author":"S Bout-Tabaku","year":"2007","unstructured":"Bout-Tabaku S, Rivas-Chacon R, Restrepo R (2007) Systemic lupus erythematosus in a\u00a0patient with etanercept for polyarticular juvenile rheumatoid arthritis. J\u00a0Rheumatol 12:2503\u20132504","journal-title":"J Rheumatol"},{"key":"4071_CR3","doi-asserted-by":"crossref","first-page":"R545","DOI":"10.1186\/ar1715","volume":"7","author":"M Bant De","year":"2005","unstructured":"De Bant M, Sibilia J, Le Loet X, Club Rhumatismes Inflammation et al (2005) Systemic lupus erythematosus induced by anti-tumor necrosis factor alpha therapy: a\u00a0French survey. Arthritis Res Ther 7:R545\u2013R551","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"4071_CR4","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0961203309106176","volume":"18","author":"AV Marzano","year":"2009","unstructured":"Marzano AV, Vezzoli P, Crosti C (2009) Drug-induced lupus: an update on its dermatologic aspects. Lupus 18(11):935\u2013940","journal-title":"Lupus"},{"key":"4071_CR5","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s00105-016-3844-9","volume":"9","author":"P Mayser","year":"2016","unstructured":"Mayser P (2016) Terbinafin: Medikamenteninduzierter Lupus und Triggerung psoriatischer Hautver\u00e4nderungen. Hautarzt 9:724\u2013731","journal-title":"Hautarzt"},{"key":"4071_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0733-8635(02)00016-5","volume":"3","author":"P Patel","year":"2002","unstructured":"Patel P, Werth V (2002) Cutaneous lupus erythematosus: a\u00a0review. Dermatol Clin 3:373\u2013385","journal-title":"Dermatol Clin"},{"key":"4071_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","volume":"5","author":"BR Reed","year":"1985","unstructured":"Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA (1985) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 5:49\u201351","journal-title":"Ann Intern Med"},{"key":"4071_CR8","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0025-6196(11)60668-X","volume":"11","author":"DA Wetter","year":"2009","unstructured":"Wetter DA, Davis MDP (2009) Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8\u2011year period at Mayo Clinic. Mayo Clin Proc 11:979\u2013984","journal-title":"Mayo Clin Proc"},{"key":"4071_CR9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-4632.2011.04871.x","volume":"5","author":"VL Williams","year":"2011","unstructured":"Williams VL, Cohen PR (2011) TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 5:619\u2013625","journal-title":"Int J Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-017-4071-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-017-4071-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T11:30:15Z","timestamp":1515583815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-017-4071-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,26]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1007\/s00105-017-4071-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,26]]}}}